Skip to:

With $6.6 million award from PCORI, UCLA scientists to study effectiveness of strategies designed to increase the use of the HPV vaccine to prevent cancer

Five-year project could help to inform national efforts to improve HPV vaccination in underserved populations.

Share: 
Date: 
Thursday, November 30, 2017

Written by the UCLA Jonsson Comprehensive Cancer Center

UCLA researcher Dr. Roshan Bastani will lead a $6.6 million research study awarded by the Patient-Centered Outcomes Research Institute (PCORI) to investigate the comparative effectiveness of strategies designed to increase receipt of the human papillomavirus (HPV) vaccine among adolescents. By advancing the understanding of which health system interventions are most effective and efficient, the research has the potential to dramatically increase HPV vaccination and prevent HPV-related cancers nationwide.

For this study, the UCLA Jonsson Comprehensive Cancer Center and the UCLA Fielding School of Public Health are partnering with the Northeast Valley Health Corporation (NEVHC), a multi-site Federally Qualified Health Center (FQHC) that provides much needed health care to a primarily uninsured or publicly insured, low-income, Latino population in Los Angeles County.

Read the full article from the UCLA Jonsson Comprehensive Cancer Center